HyperVue Imaging System with X1-FFR
Coronary Artery Disease - PCI Guidance
Key Facts
About SpectraWAVE
SpectraWAVE is a private, commercial-stage medical device company based in Cambridge, Massachusetts, focused on transforming coronary care. The company's integrated HyperVue platform merges high-definition intravascular imaging (DeepOCT+NIRS) with an AI-enabled, wire-free fractional flow reserve (FFR) measurement tool (X1-FFR), designed to streamline workflow in the catheterization lab. With 50+ employees and a vertically integrated operation in Bedford, MA, SpectraWAVE targets the significant global market for coronary artery disease by providing a unified solution for anatomical and physiological assessment. The company received 510(k) clearance for its X1-FFR technology in October 2025, marking a key regulatory milestone.
View full company profile